Avalon Ventures XI, L.P. → Janux Therapeutics, Inc. JANX

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 5.51

7,744,629 shares short · -22.7% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $13.27M

Point72 Asset Mgmt

Other 13D/G Filings on Janux Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2025-03-10	SCHEDULE	RA CAPITAL MANAGEMENT, L.P.	19.90%	11,971,377	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →